Navigation Links
Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
Date:9/19/2007

REINACH and BASEL, Switzerland, September 19 /PRNewswire-FirstCall/ -- Arpida Ltd (SWX: ARPN) was invited to present preclinical data at the poster summary session of new antimicrobial agents at the 47th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago. ICAAC is a major scientific conference where thousands of scientists and clinicians from all over the world gather to discuss the latest developments in the field of infectious diseases.

Dr Stephen Hawser, Director Microbiology of Arpida Ltd, summarized a large body of data on the novel class of 1,3-diphenylureas. His summary highlighted data generated in-house and by leading external laboratories on the promising in vitro and in vivo activity of AR-2474 against panels of bacteria known to cause topical infections, e.g., of the skin and the eye. The panel included multi-drug resistant strains of Staphylococcus aureus (both nosocomial and community-acquired), Streptococcus pyogenes and Streptococcus pneumoniae.

Dr Sergio Lociuro, Head of Research of Arpida Ltd, commented: AR-2474 originates from our own research discovery programs. We have successfully moved the compound from discovery to preclinical proof of concept. In two in vivo models, a preliminary topical formulation of AR-2474 was at least as efficacious as the gold standard mupirocin. We are currently conducting additional preclinical test with a view to progressing the compound into tolerability studies in the medium term. AR-2474 targets an area with a large and urgent medical need as many of the older topical drugs are progressively losing their efficacy.

About Arpida Ltd.

Arpida (SWX: ARPN) is a biopharmaceutical company with research facilities near Basel, Switzerland and in the USA. It focuses on the discovery and development of novel drugs that seek to overcome the growing problem of microbial resistance.

Arpida's leading product candidate is intravenous iclaprim, a broad-sp
'/>"/>

SOURCE Arpida
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Why companies dont get invited to the DEMO conference
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., PARSIPPANY, N.J., Nov. 5 DSM Pha...ade a manufacturing alliance with Galenix, Saint J...ed commercial scale manufacturing partner for Gale...SM and Galenix will collaborate on business develo...very technologies, based on the strength of Galeni...
(Date:11/5/2009)..., LYNBROOK, N.Y., Nov. 5 ... a biopharmaceutical company developing first-in-c...ts financial results for the third quarter ended S... that, in September of this year, the FDA,s Arthri... a vote of 12-0, the approval of XIAFLEX(TM) for t...
(Date:11/5/2009)..., AUSTIN, Texas, Nov. 5 SpineSmith...Osteo, Inc. to co-develop a unique scaffold that m...ollowing evaluation of several commercial products...nt, the company believes the GenOsteo scaffold rep...at creates a unique and ideal environment for the ...
(Date:11/4/2009)... This webinar, which will be ...one working in continuous flow chemistry processin...low cell inline using various meso and micro scale...f over 670 publications has been recognized with s...st recently the 2009 Tetrahedron Prize. , ...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...elixis,Inc. (Nasdaq: EXEL ) announced earlier tod...ommitment from Deerfield Management. The arrangeme...ive conference call at 5:00 a.m.,PT/8:00 a.m. ET t...the,discussion, visit the Event Calendar page unde...ay of the conference call will be available until ...
...ne Control, Trait Stacking in ...MOND, Calif., June 5 Dow,AgroSciences LLC and San...today the successful completion of research milest...l License Agreement. These milestones represent,th...DNA-binding protein,(ZFP) technology to the genera...
...C Santa Barbara,s Solid-State Lighting and Energy ...nce of Asturias Award for Technical and Scientific... is presented with a medal and a Joan Miro sculptu...ecipients in each category also share a 50,000 (US...esearch prize is given annually to "the individual...
Other Biology Technology:Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 2Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 3Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 4Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 5
(Date:11/4/2009)...ewswire-FirstCall/ -- Quest Diagnostics Incorporat...diagnostic testing, information and services, anno...0, 2009, income from continuing operations rose to...60 million, or $0.81 per diluted share, for the th...s were reduced by a $0.03 per share charge associa...
(Date:11/4/2009)...PRNewswire/ -- GenVault Corporation, the leader in...mic discovery, medicine and identification, today ...sident and CEO, will be presenting at the BIOCOM I...d 27th in La Jolla, CA. ,, During the presentat...mpany together with recent customer, technical and...
(Date:11/4/2009)...RNewswire/ -- GenVault Corporation (Carlsbad, CA) ...as joined its Board of Directors. Dr. Brody, the ...ute, is an acclaimed physician-scientist and unive..., Dr. Brody served as president of The Johns Hopki...demy of Engineering and the Institute of Medicine,...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 1SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 1REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 3REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 4REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 5Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 1Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 2
...y (ASH TM ) and American Board of Internal Medicin...a new wave of performance evaluation tools for blo...uirements to maintain ABIM certification, ASH and ...rovement Module (PIM), a web-based tool physicians...ment requirement for recertification. Participants...
...is the deadliest form of the disease, with fewer t...ear prognosis for survival. To find out what drive...d to rapidly screen for drugs that might stop IBC... Diego (UCSD), have come up with an unlikely yet ...ble for xenografts. , More properly, it’s a trans...
...s are heading a worldwide research project which c...diarrhoea in children in developing countries. , T... being piloted in four hospitals in India, will of...ms of the disease quickly, cheaply and with little...ications for improving children,s health could be ...
Other Biology News:New tool helps blood specialists improve patient care 2A fisheye view of the deadliest breast cancer 2Hope for major advance in fighting world killer disease 2Hope for major advance in fighting world killer disease 3
Mouse Anti-Catenin, beta, N-terminal (exon 2) Monoclonal Antibody, Unconjugated, Clone BDI710 from Meridian Life Science, Inc.
Anti-CaMKII (Calmodulin-dependent Protein Kinase II) Monoclonal Antibody, Unconjugated, Clone 6G9 (2) from CHEMICON
Rabbit Anti-SLAP-2 Polyclonal Antibody, Unconjugated from Calbiochem
...s ligand immobilization can be coupled with a liga...or to create an affinity matrix of choice. Affi-Ge...rimary amines. Affi-Gel 10 gel couples neutral or ... gel couples acidic proteins with pI less than 6.5...
Biology Products: